NTRA Cash-Secured Put Strategy

NTRA (Natera, Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NASDAQ.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays.

NTRA (Natera, Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $27.97B, a beta of 1.57 versus the broader market, a 52-week range of 131.811-256.36, average daily share volume of 1.3M, a public-listing history dating back to 2015, approximately 4K full-time employees. These structural characteristics shape how NTRA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.57 indicates NTRA has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a cash-secured put on NTRA?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current NTRA snapshot

As of May 15, 2026, spot at $189.07, ATM IV 50.00%, IV rank 21.83%, expected move 14.33%. The cash-secured put on NTRA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this cash-secured put structure on NTRA specifically: NTRA IV at 50.00% is on the cheap side of its 1-year range, which means a premium-selling NTRA cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 14.33% (roughly $27.10 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NTRA expiries trade a higher absolute premium for lower per-day decay. Position sizing on NTRA should anchor to the underlying notional of $189.07 per share and to the trader's directional view on NTRA stock.

NTRA cash-secured put setup

The NTRA cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NTRA near $189.07, the first option leg uses a $180.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NTRA chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NTRA shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$180.00$7.05

NTRA cash-secured put risk and reward

Net Premium / Debit
+$705.00
Max Profit (per contract)
$705.00
Max Loss (per contract)
-$17,294.00
Breakeven(s)
$172.95
Risk / Reward Ratio
0.041

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

NTRA cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on NTRA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price% From SpotP&L at Expiration
$0.01-100.0%-$17,294.00
$41.81-77.9%-$13,113.67
$83.62-55.8%-$8,933.34
$125.42-33.7%-$4,753.01
$167.22-11.6%-$572.67
$209.03+10.6%+$705.00
$250.83+32.7%+$705.00
$292.63+54.8%+$705.00
$334.44+76.9%+$705.00
$376.24+99.0%+$705.00

When traders use cash-secured put on NTRA

Cash-secured puts on NTRA earn premium while a trader waits to acquire NTRA stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning NTRA.

NTRA thesis for this cash-secured put

The market-implied 1-standard-deviation range for NTRA extends from approximately $161.97 on the downside to $216.17 on the upside. A NTRA cash-secured put lets a trader earn premium while waiting to acquire NTRA at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current NTRA IV rank near 21.83% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on NTRA at 50.00%. As a Healthcare name, NTRA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NTRA-specific events.

NTRA cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NTRA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NTRA alongside the broader basket even when NTRA-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on NTRA carry tail risk when realized volatility exceeds the implied move; review historical NTRA earnings reactions and macro stress periods before sizing. Always rebuild the position from current NTRA chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on NTRA?
A cash-secured put on NTRA is the cash-secured put strategy applied to NTRA (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With NTRA stock trading near $189.07, the strikes shown on this page are snapped to the nearest listed NTRA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are NTRA cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the NTRA cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 50.00%), the computed maximum profit is $705.00 per contract and the computed maximum loss is -$17,294.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a NTRA cash-secured put?
The breakeven for the NTRA cash-secured put priced on this page is roughly $172.95 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current NTRA market-implied 1-standard-deviation expected move is approximately 14.33%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on NTRA?
Cash-secured puts on NTRA earn premium while a trader waits to acquire NTRA stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning NTRA.
How does current NTRA implied volatility affect this cash-secured put?
NTRA ATM IV is at 50.00% with IV rank near 21.83%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related NTRA analysis